CONMED Corp — Director's Dealing 2023

Jun 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-06-09

Reporting Person: SHAGORY PETER K (EVP, STRAT & CORP DEVT)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-09	Common Stock	M	4500	$55.42	Acquired	6361	Direct
2023-06-09	Common Stock	F	2650	$132.44	Disposed	3711	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-09	Sars (Stock Appreciation Rights)	$55.42	M	4500	Disposed	2025-05-11	Common Stock (4500)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.